References References 1. Abbott, B.J., Developmental Therapeutics Program, 14. Ader, R., Greta, L.J., and Cohen, N., “Conditioning National Cancer Institute, National Institutes of Phenomena and Immune Function,” Ann. N.X Health, U.S. Department of Health and Human Acad. Sci. 496:532-544, 1987. Services, letter to C. Schleicher, M.D., President, 15. Aihara, H., Acid and Alkaline (Oroville, CA: Mankind Research Foundation, Silver Spring, MD, George Ohsawa Macrobiotic Foundation, 1986). October 24, 1978. 16. Aihara, H., Basic Macrobiotics (New York, NY: 2. Abbott, B.J., Developmental Therapeutics program, Japan Publications, 1985). National Cancer Institute, National Institutes of 17. Alliance for Alternative Medicine, “The Alliance Health, U.S. Department of Health and Human for Alternative Medicine,” unpublished position Services, Bethesda, MD, personal communications, paper, Liberty Lake, WA, November 20, 1987. 1988 and 1989. 3. Acevedo, H.F., Campbell-Acevedo, E., and Kloos, 18. Alliance for Alternative Medicine, “Dear Friend,” form letter, Liberty Lake, WA, undated. W.E., “ExPRxsionof Human chorion.ic ~ph- like Material in Coagulase Negative Staphylococ- 19. Alliance for Alternative Medicine, “Welcomes cus Species,” Infect. Immun. 50(3):860-868, 1985. Members of Congress and Invited Guests to Our 4. Acevedo, H.F., Pardo, M., Campbell-Acevedo, E., Screening of the Acclaimed Film, ‘Hoxsey: Quacks et al., “Human Choriogonadotropin-like Material Who Cure Cancer?’ “ undated pamphlet. in Bacteria of Different Species: Electron Micros- 20. Alternatives, “Halfis Formally Launched,” Alterna- copy and Immunocytochemical Studies with Mono- tives 1(1):1,4, 1986. clinal and Polyclonal Antibodies,” J. Gen. Micro- 21. Alvarez, W. C., “Origin of the So-called Auto- biol. 133:783-791, 1987. Intoxication Symptoms,” JJLM.A. 72:8-13, 1919. 5. Acevedo, H.F., Slifkin, M.: Pouchet, G.R., et al., 22. American Biologics, Tijuana, Mexico, patient bro- “Immunohistochemical Localization of a Chori- chure, undated. onic Gonadotropin-like Protein in Bacteria Isolated 22a. American Cancer Society, Unproven Methods of From Cancer Patients,” Cancer 41:1217-1229, Cancer Management, (untitled), CA 11(2):67-68, 1978. 1961. 6. Achterberg, J., Imagery in Healing: Shamanism and 23. American Cancer Society, “Unproven Methods of Modern Medicine (Boston, MA: New Science Cancer Treatment: Livingston Vaccine,” CA 18(1):46- Library, 1985). 47, 1968. 7. khterberg, J., “Recommendations for a Disci- 24. American Cancer Society, “Unproven Methods of plinedInquiry: Unconventional CancerTreatments,’ Cancer Management: Hydrazine Sulfate,” CA 26(2): typescript, March 10, 1990. 108-110, 1976. 8. Achterberg, J., Block, K., Coh, J., Fink, J., Hildebrand, G., Wrner, M., O’Regan, B., Weil, A., 25. American Cancer Society, ” 1986 Cancer Facts and Figures, “ New York, NY, 1986. “Joint letter from selected OTA Advisory Panel Members,” March 25, 1990. 26. American Cancer Society, Cancer Response Sys- 9. Adams, D., Member, Friends of Dr. Revici, Washing- tem, “Fresh Cell Therapy,” typescript, October 5, ton, DC, personal communication, April 1987. 1987. 10. Adams, J., Clinical Research Pharmacist, Division 27. American Cancer Society, Cancer Response Sys- of Cancer Treatment, National Cancer Institute, tem, “Immuno-Augmentative Therapy-Dr. Law- National Institutes of Health, U.S. Department of rence Burton,” Number 8,329, typescript, October Health and Human Services, Bethesda, MD, per- 1987. sonal communication, August 1988. 28. American Cancer Society, “Unproven Methods of 11. Ader,R. (ed.),Psychoneuroimmurwlogy (New Yorlq CancerManagement,” pamphlet, 87-25M-No. 3028, NY: Academic Press, 1981). 1987. 12. Ader, R., “Clinical Implications of Psychoneuroim- 29. American Cancer Society, “Unproven Methods of munology,” J. Dev. Behav. Pediatr. 6(6):357-358, Cancer Management: International Association of 1987. Cancer Victors and Friends,” CA 39(1):58-59, 13. Ader, R., and Cohen, N., “Conditioned Immuno- 1989. pharmacologic Responses,” Psychoneuroimmunol- 30. American Cancer Society, “Unproven Methods of ogy, R. Ader (cd.) (New York, NY: Academic Cancer Management: Macrobiotic Diets for the Press, 1981). Treatment of Cancer,” CA 39(4):248-251, 1989. –257– 258 ● Unconventional Cancer Treatments 31. American Cancer Society, “Unproven Methods of Therapy: A Guide for the Layperson,” J. CZin. Cancer Management: Revici Method,” CA 39(2): Oncol. 1(2):154-63, February 1983. 119-122,1989. 49. Anderson, A., Jr., ‘‘The Politics of Cancer: How Do 32. American Cancer Society, “Immuno-Augmenta- You Get the Medical Establishment to Listen?” tive Therapy,” statement on “Unproven Methods New York 7(30):42-46, 1974. of Cancer Management,’ typescript, undated. 50. Andrews, L. B., Deregulating Doctoring: Do Medi- 33. American Cancer Society, Delaware Division, Inc., cal Licensing Luws Meet Tockzy’s Health Care ‘‘UnprovenMethods Information Service,” mimeo- Needs? (Emmaus, PA: People’s Medical Society, graph, Wilmington, DE, March 1987. 1983). 34. American College of Physicians, ‘Parenteral Nutri- 51. Arizona v. Wickham, Sup. Ct., Co. of Maricopa, Az. tion in Patients Receiving Cancer Chemotherapy,’ CR 1384420 (1984), as cited in R.D. Schwartz, and Ann. Intern. Med. 110(9):734-736, 1989. R.L. Burke, “hgal Constraints on the Availability 35, American Health Foundation, “bw Fat Diet in of Unorthodox Cancer Treatments: Consumer Pro- Stage II Breast Cancer— Randomized Study,” tection Viewpoint,” prepared for the Office of (protocol), E.L. Wynder, Principal Investigator, Technology Assessment, U.S. Congress, Washing- typescript, undated. ton, DC, April 1988. 36. American Home Products Corp. v. F. T.C., 695 F.2d 52. Arnan, M., and DeVries, L.E., “Effect of Ozone/ 681,687 (3d Cir. 1982). Oxygen Gas Mixture Directly Injected Into the 37. American Journal of Law and Medicine, “Selected Mammary Carcinoma of the Female C3H/HEJ Recent Court Decisions: Third-Party Reirnbursement— Mice,” J. Holistic Med. 7(1):31-37, 1985. Laetrile Treatment—Free v. Travelers Insurance 53. Arnold, C., “The Macrobiotic Diet: A Question of Co.,” Am. J. Law Med. 9(1):103-116, Spring 1983. Nutrition,” Oncol. Nurs. Forum 11(3):50-53, 1984. 38. American Medical Association, “Proceedings of the Annual Meeting of the House of Delegates,” 54. Arntson, P., “The Network: How Patients barn 1913-1975. About and Gain Access to Unorthodox Cancer 39. American Medical Association, Council on Phar- Treatments,” prepared for the Office of Technology macy and chemistry, “Cancer and the Need for Assessment, U.S. Congress, Washington, DC, March 1988. Facts,” J.A.M.A. 139(2):93-98, 1949. 40. American Medical Association, “Proceedings of 55. Arntson, P., Northwestern University, Evanston, IL, the Annual Meeting of the House of Delegates, ” personal communication, 1987. 1961-1969. 56. Aronson, N., Manager, Technology Evaluation and 41. American Medical Association, “Proceedings of Coverage, Blue Cross and Blue Shield Association, the Annual Meeting of the House of Delegates,” Chicago, IL, personal communications, August 1967. 1988 and September 1988. 42. American Medical Association, Digest of Official 56a. Association of Food and Drug Officials of the Actions, 1969-1978. United States, Quarterly Bulletin: Uniform State 43. American Medical Association, Council on Foods Food, Drug and Cosmetic Bill, Revised Form, 2d and Nutrition, “Zen Macrobiotic Diets,” J.A.M.A. Supplemental Issue, 1969. 218(3):397, 1971. 57. Athar, M., Raza, H., Bickers, D.R., et al., “Inhibi- 44. American Medical Association, “Proceedings of tion of Benzoyl Peroxide-mediated ‘llunor Promo- the Annual Meeting of the House of Delegates,” tion in 7,12-Dirnethylbenz(a)anthracene-initiated 1975. Skin of Sencar Mice by Antioxidants Nordihy- 45. American Medical Association, Council on Scien- droguaiaretic Acid and Diallyl Sulfide,” J. Invest. tific Affairs, “Dimethyl Sulfoxide: Controversy Derrnatol. 94:162-165, 1990. and Current Status-1981,” typescript. 58. Ausubel, K., “The Troubling Case of Harry 46. American Medical Association, “DA~A Evalua- Hoxsey,” New Age, pp. 4347,49,78-79,86, July/ tion Update: Hyperthermia Treatment for Cancer,’ August 1988. unpublished report reflecting the views of DA3TA 59. Ausubel, K., and Salveson, C., producers, “Hoxsey: panelists and reports in the scientific literature as of Quacks Who Cure Cancer?” Realidadl?roductions, September 1984. Inc., Santa Fe, NM, 1987. 47. American Medical Association, 1986 Annual Re- 60. Avery, R. J., Office of Cancer Communications, port (Chicago, IL: American Medical Association, National Cancer Institute, National Institutes of 1986). Health, U.S. Department of Health and Human 48. American Society of Clinical Oncology, Subcommitt- Services, letter to G. Dego, University of London, ee on Unorthodox Therapies, “Ineffective Cancer August 24, 1982. References .259 61. Awang, D.V.C., “Commercial Taheebo Lacks Ac- 78. Bio-Medical Center, Information sheet on Hoxsey tive Ingredient,” Can. Pharm. J. 121(5):323-326, Therapy, typescript, undated. 1988. 79. BlackStein, M.E., and Bergsagel, D.E., ‘The Treat- 62. BackUs, B.T, and Affronti, L.F., “Tuor Associ- ment of Cancer Patients With Antineoplastons and ated Bacteria Capable of Producing a Human the Burzynski Clinic in Houston, Texas,’ Report to Choriogonadotropin-like Substance,” I#ect. Immun. the Ministry of Health, Province of Ontario, type- 32:1211-1215, 1981. script, 1982. 63. Bailar, J. C., “Rethinking the War on Cancer,” 80. Bland, J., and Bradford, R., cited in L. Chaitow, Issues